View all IQVIA events
SOLUTIONS
-
Life Sciences Solutions
-
Healthcare Solutions
-
Medical Device and Diagnostic
-
U.S. Government
Life Sciences Solutions
Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreLife Sciences Solutions
Healthcare Solutions
Accelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreHealthcare Solutions
Medical Device and Diagnostic Solutions
Your world is unique – and quite different from pharma. In the U.S., decision-making has shifted from individual physicians to integrated networks--GPOs, IDNs and payers. These groups have heightened the focus on proving your solution’s value, demanding outcomes analyses and putting pressure on pricing.
Learn MoreMedical Device and Diagnostic Solutions
U.S. Government Solutions
For government agencies and organizations at every level—from federal or national to regional and local—Big Data can have a huge impact on public health.
Learn MoreU.S. Government Solutions
U.S. PROGRESS POINT
A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREU.S. BLOGS
Get the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!
LEARN MOREThe title model is an option for organizations that allows them to sell their products. In this webinar, our experts will discuss the benefits and challenges of the title model, and reasons organizations would want to consider when electing to outsource their licensing services.
Key takeaways:
- Summary of this type of licensing model
- Impact of the title model on the sales and licensing aspects of a business
- Licensing responsibilities an entity will still have under the title model
- Factors to consider when entering and/or exiting this model
Speakers:
Liz Updike
Director and Sr. Attorney, State Services, IQVIA
Lisa Butler
Director, State Licensing, DEA & PDMA Compliance, Novartis Pharmaceuticals Corporation